Chris DAdamo (University of Maryland) to run a clinical and efficacy study on the myGLP System: Consumer study demonstrated positive results
In many people with obesity or type 2 diabetes, GLP-1 levels are lower or not as effective
Understanding the key contrasts between the two medications will help you make an informed decision about which treatment may be right for you
Khalil M, Shanmugam H, Abdallah H, John Britto JS, Galerati I, Gmez-Ambrosi J, Frhbeck G, Portincasa P (2022) The potential of the Mediterranean Diet to improve mitochondrial function in experimental models of obesity and metabolic syndrome
The two companies are investing $750 million, which is expected to create 400 new jobs
Your treatment should reflect your biology, your goals, and your lab trends, tolerance, and clinical progress